CLINICAL_TRIALS ClinicalTrials.gov record update

Study to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC Given With Infanrix™ Penta Versus NeisVac-C™ Given With Infanrix™ Hexa at 3, 5 Months of Age and Persistence Prior to a Hib-MenC Booster at 11 Months and Immunogenicity of the Booster

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00327184
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:25.157582+00:00
Published At: 2016-10-07T00:00:00+00:00
Record Updated At: 2016-10-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neisseria Meningitidis", "Haemophilus Influenzae Type b"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-10-07"
protocolSection.identificationModule.nctId: "NCT00327184"
protocolSection.identificationModule.officialTitle: "Study to Demonstrate Non-inferiority of GSK Biologicals\u0027 Hib-MenC Given With Infanrix\u2122 Penta Versus NeisVac-C\u2122 Given With Infanrix\u2122 Hexa at 3, 5 Months of Age and Persistence Prior to a Hib-MenC Booster at 11 Months and Immunogenicity of the Booster"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.